Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review
Zsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunity
Fiona Errington, Lynette Steele, Robin Prestwich, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
March 21, 2024
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy
Zsuzsanna Iyizoba-Ebozue, Emma Nicklin, James Price, et al.
BMC Cancer
|
June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
Lucy Heinemann, Guy R Simpson, Angela Boxall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 26, 2018
Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma
Lynne Dixon, Satiavani Ramasamy, Kate Cardale, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 22, 2025
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study
Sebastian Søby, Robin Prestwich, Niels Gyldenkerne, et al.
Molecular Immunology
|
December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
Jehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 18, 2025
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study
Zsuzsanna Iyizoba-Ebozue, Emma Nicklin, Stuart Currie, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 1, 2025
Neurocognitive concerns and neurocognitive impairment in long-term survivors of oropharyngeal cancer post (chemo)radiotherapy
Zsuzsanna Iyizoba-Ebozue, Robin Prestwich, Maryse Luijendijk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 25, 2009
Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery
Emma West, Ruth Morgan, Karen Scott, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review
Zsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunity
Fiona Errington, Lynette Steele, Robin Prestwich, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
March 21, 2024
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy
Zsuzsanna Iyizoba-Ebozue, Emma Nicklin, James Price, et al.
BMC Cancer
|
June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
Lucy Heinemann, Guy R Simpson, Angela Boxall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 26, 2018
Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma
Lynne Dixon, Satiavani Ramasamy, Kate Cardale, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 22, 2025
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study
Sebastian Søby, Robin Prestwich, Niels Gyldenkerne, et al.
Molecular Immunology
|
December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
Jehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 18, 2025
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study
Zsuzsanna Iyizoba-Ebozue, Emma Nicklin, Stuart Currie, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 1, 2025
Neurocognitive concerns and neurocognitive impairment in long-term survivors of oropharyngeal cancer post (chemo)radiotherapy
Zsuzsanna Iyizoba-Ebozue, Robin Prestwich, Maryse Luijendijk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 25, 2009
Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery
Emma West, Ruth Morgan, Karen Scott, et al.
Page
of 4